Sign in
Active, not recruitingNo phase

CoreHip - Post Market Clinical Follow-Up Study

Key facts

Who runs it
Aesculap AG
Where
Germany and Switzerland6 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
248 people enrolled
Started
16 Oct 2018
Expected to end
Dec 2028
Type of study
Observational
Treatments tested
  • CoreHip Total Hip Arthroplasty
Record updated
31 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patient age ≥ 18 years
  • Indication for THA with a CoreHip® stem
  • Written informed consent

Who cannot take part

  • Patient age < 18 years
  • Pregnancy
  • Patient not able to regularly participate at the follow-up examinations

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

The group in the trial

  • CoreHip

    Clinical and Radiological Data of 300 patients of a Standard Patient Population, who are treated with CoreHip Total Hip Arthroplasty for Indications according to the Instructions for Use (IfU) with a five year follow Up

    Treatment: CoreHip Total Hip Arthroplasty

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective, Non-Interventional, Multicenter, Post-Market Clinical Follow-up Study CoreHip®
Record updated
31 March 2026